Accuray Return on Tangible Equity 2010-2024 | ARAY
Current and historical return on tangible equity values for Accuray (ARAY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Accuray Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-03-31 | $-0.02B | $-0.02B | 231.58% |
| 2023-12-31 | $-0.02B | $-0.01B | 250.00% |
| 2023-09-30 | $-0.01B | $-0.01B | 140.00% |
| 2023-06-30 | $-0.01B | $-0.00B | 150.00% |
| 2023-03-31 | $-0.01B | $-0.00B | 144.00% |
| 2022-12-31 | $-0.01B | $-0.01B | 151.72% |
| 2022-09-30 | $-0.01B | $-0.01B | 120.00% |
| 2022-06-30 | $-0.01B | $-0.01B | 62.50% |
| 2022-03-31 | $-0.01B | $-0.01B | 305.88% |
| 2021-12-31 | $-0.01B | $-0.01B | -480.00% |
| 2021-09-30 | $-0.01B | $-0.01B | -77.78% |
| 2021-06-30 | $-0.01B | $0.01B | -41.38% |
| 2021-03-31 | $0.01B | $0.02B | 37.74% |
| 2020-12-31 | $0.01B | $0.02B | 94.12% |
| 2020-09-30 | $0.01B | $0.01B | 430.77% |
| 2020-06-30 | $0.01B | $0.01B | -153.85% |
| 2020-03-31 | $0.00B | $0.00B | -59.26% |
| 2019-12-31 | $0.00B | $-0.00B | 0.00% |
| 2019-09-30 | $-0.02B | $-0.02B | 130.61% |
| 2019-06-30 | $-0.02B | $-0.01B | 148.84% |
| 2019-03-31 | $-0.02B | $-0.01B | 145.45% |
| 2018-12-31 | $-0.02B | $-0.01B | 204.26% |
| 2018-09-30 | $-0.02B | $-0.01B | 213.33% |
| 2018-06-30 | $-0.02B | $-0.01B | 218.18% |
| 2018-03-31 | $-0.03B | $-0.01B | 243.48% |
| 2017-12-31 | $-0.02B | $-0.01B | 208.70% |
| 2017-09-30 | $-0.03B | $-0.01B | 219.61% |
| 2017-06-30 | $-0.03B | $-0.01B | 227.45% |
| 2017-03-31 | $-0.03B | $-0.01B | 275.56% |
| 2016-12-31 | $-0.03B | $-0.02B | 277.78% |
| 2016-09-30 | $-0.02B | $-0.01B | 293.33% |
| 2016-06-30 | $-0.03B | $-0.01B | 370.37% |
| 2016-03-31 | $-0.02B | $-0.01B | 505.26% |
| 2015-12-31 | $-0.03B | $-0.01B | 861.54% |
| 2015-09-30 | $-0.03B | $-0.01B | 2133.33% |
| 2015-06-30 | $-0.04B | $0.00B | -8200.00% |
| 2015-03-31 | $-0.05B | $0.00B | -1058.82% |
| 2014-12-31 | $-0.05B | $-0.00B | -671.43% |
| 2014-09-30 | $-0.04B | $0.00B | -420.00% |
| 2014-06-30 | $-0.04B | $0.02B | -313.04% |
| 2014-03-31 | $-0.05B | $0.01B | -400.00% |
| 2013-12-31 | $-0.07B | $0.01B | -458.06% |
| 2013-09-30 | $-0.10B | $0.01B | -355.14% |
| 2013-06-30 | $-0.10B | $0.02B | -240.94% |
| 2013-03-31 | $-0.10B | $0.03B | -166.40% |
| 2012-12-31 | $-0.09B | $0.06B | -107.32% |
| 2012-09-30 | $-0.07B | $0.07B | -70.77% |
| 2012-06-30 | $-0.07B | $0.10B | -65.45% |
| 2012-03-31 | $-0.08B | $0.11B | -66.24% |
| 2011-12-31 | $-0.06B | $0.12B | -47.28% |
| 2011-09-30 | $-0.05B | $0.12B | -33.28% |
| 2011-06-30 | $-0.03B | $0.12B | -17.09% |
| 2011-03-31 | $0.00B | $0.18B | 1.77% |
| 2010-12-31 | $0.01B | $0.17B | 3.64% |
| 2010-09-30 | $0.00B | $0.16B | 0.63% |
| 2010-06-30 | $0.00B | $0.17B | 1.92% |
| 2010-03-31 | $-0.00B | $0.16B | -0.66% |
| 2009-12-31 | $-0.00B | $0.15B | -1.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.159B | $0.448B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.743B | 27.48 |
| Intuitive Surgical (ISRG) | United States | $141.891B | 85.48 |
| Edwards Lifesciences (EW) | United States | $54.101B | 35.21 |
| DexCom (DXCM) | United States | $51.973B | 78.73 |
| IDEXX Laboratories (IDXX) | United States | $43.777B | 51.31 |
| Alcon (ALC) | Switzerland | $43.442B | 31.13 |
| IQVIA Holdings (IQV) | United States | $41.922B | 24.32 |
| STERIS (STE) | Ireland | $22.999B | 26.88 |
| Waters (WAT) | United States | $21.000B | 30.86 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.908B | 0.00 |
| Hologic (HOLX) | United States | $17.468B | 19.54 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.869B | 15.02 |
| ShockWave Medical (SWAV) | United States | $12.384B | 77.07 |
| Sysmex ADR (SSMXY) | Japan | $11.134B | 34.91 |
| Teleflex (TFX) | United States | $10.108B | 15.73 |
| Globus Medical (GMED) | United States | $8.970B | 26.29 |
| Penumbra (PEN) | United States | $7.809B | 88.74 |
| Masimo (MASI) | United States | $6.723B | 38.73 |
| Glaukos (GKOS) | United States | $5.504B | 0.00 |
| TransMedics (TMDX) | United States | $4.566B | 433.19 |
| Integer Holdings (ITGR) | United States | $4.029B | 24.34 |
| PROCEPT BioRobotics (PRCT) | United States | $3.533B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.318B | 19.70 |
| Tandem Diabetes Care (TNDM) | United States | $3.051B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.973B | 20.40 |
| Inari Medical (NARI) | United States | $2.682B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.474B | 20.92 |
| RxSight (RXST) | United States | $2.317B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.126B | 9.27 |
| Veracyte (VCYT) | United States | $1.705B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.543B | 0.00 |
| Artivion (AORT) | United States | $0.993B | 95.24 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.933B | 18.14 |
| OPKO Health (OPK) | United States | $0.920B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.897B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.775B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.656B | 22.26 |
| Paragon 28 (FNA) | United States | $0.621B | 0.00 |
| SiBone (SIBN) | United States | $0.593B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.567B | 0.00 |
| IRadimed (IRMD) | United States | $0.555B | 31.07 |
| Pacific Biosciences Of California (PACB) | United States | $0.523B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.474B | 0.00 |
| Nevro (NVRO) | United States | $0.386B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.324B | 11.10 |
| Treace Medical Concepts (TMCI) | United States | $0.306B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.282B | 0.00 |
| AxoGen (AXGN) | United States | $0.271B | 0.00 |
| 908 Devices (MASS) | United States | $0.236B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.233B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.231B | 0.00 |
| NeuroPace (NPCE) | United States | $0.230B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.207B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.201B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.189B | 0.00 |
| CVRx (CVRX) | United States | $0.179B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.168B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.166B | 8.42 |
| Spectral Diagnostics (EDTXF) | Canada | $0.108B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 21.59 |
| KORU Medical Systems (KRMD) | United States | $0.101B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.091B | 0.00 |
| Neuronetics (STIM) | United States | $0.076B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Envoy Medical (COCH) | United States | $0.064B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.056B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.054B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
| LENSAR (LNSR) | United States | $0.046B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |